U.S. market Closed. Opens in 6 hours 2 minutes

HSCS | Heart Test Laboratories, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-04-302023-04-302022-04-302021-04-302020-04-30
Revenue18.60K5.15K14.37K25.60K64.18K
Cost of Revenue6.08K2.80K7.89K10.66K46.46K
Gross Profit12.52K2.35K6.48K14.94K17.72K
Operating Expenses6.32M6.12M4.72M2.58M3.84M
Selling, General & Admin3.44M3.65M1.71M874.62K1.80M
Research & Development2.88M2.46M3.00M1.71M2.04M
Other Operating Expenses54.64K1.85K2.56K-3.45K19.89K
Operating Income-6.31M-6.11M-4.71M-2.57M-3.82M
Other Expenses / Income-299.44K-241.33K-118.86K115.96K7.07K
Before Tax Income-6.61M-6.35M-4.83M-2.45M-3.81M
Income Tax Expenses-95.13K484.50M-250.20K129.00K22.70K
Net Income-6.61M-490.85M-4.58M-2.58M-3.83M
Interest Expenses-354.08K243.17K371.62K132.45K2.81K
Basic Shares Outstanding727.17K79.50K33.19K33.14K33.14K
Diluted Shares Outstanding727.17K79.50K33.19K33.14K33.14K
EBITDA-6.31M-6.08M-4.68M-2.54M-3.73M
EBITDA Margin-33,901.99%-118,139.83%-32,562.97%-9,912.39%-5,818.55%
EBIT-7.05M-6.11M-4.46M-2.32M-3.81M
EBIT Margin-37,926.99%-118,662.45%-31,007.03%-9,059.98%-5,933.61%
Financial Year End2024-04-302023-04-302022-04-302021-04-302020-04-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙